• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列医疗保健组织中乳糜泻的高昂成本。

The high cost of celiac disease in an Israeli Health Maintenance Organization.

机构信息

The Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel.

出版信息

Health Econ Rev. 2013 Nov 7;3(1):23. doi: 10.1186/2191-1991-3-23.

DOI:10.1186/2191-1991-3-23
PMID:24229448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4177202/
Abstract

BACKGROUND

The aim of this study was to identify costs in patients diagnosed with Celiac disease.

METHODS

This retrospective case control study covered the period 2003-2006 and was conducted in a large Israeli Health Maintenance Organization insuring over two million members. Our cohort comprised 1,754 patients with Celiac disease with a control group of 15,040. Costs were aggregated according to main cost-branches and computed individually for each member. A linear step wise regression was performed with costs being the dependent variable and the independent variables; age, gender and the presence of celiac disease. Costs were compared with patients suffering from other chronic diseases.

RESULTS

The total costs of the patients with celiac disease were significantly higher than that of the control group for hospital admission, medications, laboratory and imaging. Hospital admission rate was 7.98% as opposed to 7.1% for the control group (p = 0.06). When compared with other chronic illnesses, the costs of patients with celiac disease were similar to those of patients with diabetes and hypertension.

CONCLUSIONS

Patients with Celiac disease utilize medical services more than the general population. This research suggests that the use of medical resources by patients with Celiac disease may be higher than previously thought.

摘要

背景

本研究旨在确定乳糜泻患者的成本。

方法

本回顾性病例对照研究覆盖了 2003 年至 2006 年期间,并在一家大型以色列健康维护组织中进行,该组织为超过 200 万成员提供保险。我们的队列包括 1754 名乳糜泻患者,对照组为 15040 名。根据主要成本分支汇总成本,并为每个成员单独计算。成本为因变量,独立变量为年龄、性别和乳糜泻的存在,采用线性逐步回归进行分析。将成本与患有其他慢性疾病的患者进行比较。

结果

乳糜泻患者的总费用明显高于对照组,主要表现在住院、药物、实验室和影像学方面。住院率为 7.98%,而对照组为 7.1%(p=0.06)。与其他慢性疾病相比,乳糜泻患者的成本与糖尿病和高血压患者相似。

结论

乳糜泻患者比一般人群更需要使用医疗服务。本研究表明,乳糜泻患者对医疗资源的利用可能高于先前的估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c9a/4177202/ce5019ad0821/2191-1991-3-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c9a/4177202/ce5019ad0821/2191-1991-3-23-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c9a/4177202/ce5019ad0821/2191-1991-3-23-1.jpg

相似文献

1
The high cost of celiac disease in an Israeli Health Maintenance Organization.以色列医疗保健组织中乳糜泻的高昂成本。
Health Econ Rev. 2013 Nov 7;3(1):23. doi: 10.1186/2191-1991-3-23.
2
Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States.美国全国性管理式医疗人群中乳糜泻诊断率提高带来的经济效益。
J Insur Med. 2008;40(3-4):218-28.
3
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
4
The direct medical cost of cardiovascular diseases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel.以色列一家大型 HMO 中心血管疾病、高血压、糖尿病、癌症、妊娠和女性不孕的直接医疗费用。
Health Policy. 2010 May;95(2-3):271-6. doi: 10.1016/j.healthpol.2009.12.007. Epub 2010 Jan 12.
5
Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.真实世界健康计划对集群性头痛患者和无头痛相关疾病患者的医疗利用和总成本差异的分析。
Am J Manag Care. 2017 Nov;23(16 Suppl):S295-S299.
6
Costs of Managing Patients with Diabetes in a Large Health Maintenance Organization in Israel: A Retrospective Cohort Study.以色列一家大型健康维护组织中糖尿病患者的管理成本:一项回顾性队列研究
Diabetes Ther. 2017 Feb;8(1):167-176. doi: 10.1007/s13300-016-0212-9. Epub 2016 Nov 16.
7
Estimating the unit costs of public hospitals and primary healthcare centers.估算公立医院和基层医疗中心的单位成本。
Int J Health Plann Manage. 2013 Oct-Dec;28(4):320-32. doi: 10.1002/hpm.2147. Epub 2012 Nov 5.
8
Yield and cost of performing screening tests for constipation in children.儿童便秘筛查试验的产量与成本
Can J Gastroenterol. 2013 Dec;27(12):e35-8. doi: 10.1155/2013/945165. Epub 2013 Nov 13.
9
10
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.在管理式医疗环境中,识别出患有疼痛性 DPN 的患者的合并症、医疗服务利用情况和费用。
Curr Med Res Opin. 2009 Jun;25(6):1319-28. doi: 10.1185/03007990902864749.

引用本文的文献

1
Burden of coeliac disease in Germany: real-world insights from a large retrospective health insurance claims database analysis.德国乳糜泻负担:来自大型回顾性健康保险理赔数据库分析的真实世界见解
Therap Adv Gastroenterol. 2025 Feb 4;18:17562848251314803. doi: 10.1177/17562848251314803. eCollection 2025.
2
Can Celiac Disease Be Prevented?乳糜泻可以预防吗?
Front Immunol. 2021 May 14;12:672148. doi: 10.3389/fimmu.2021.672148. eCollection 2021.
3
Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis.

本文引用的文献

1
World perspective on celiac disease.全球乳糜泻视角
J Pediatr Gastroenterol Nutr. 2012 Nov;55(5):494-9. doi: 10.1097/MPG.0b013e318272adf4.
2
Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis.3646 例乳糜泻患者诊断前后的资源利用和成本分析:英国初级保健数据库分析结果。
PLoS One. 2012;7(7):e41308. doi: 10.1371/journal.pone.0041308. Epub 2012 Jul 17.
3
Screening for celiac disease in average-risk and high-risk populations.筛查普通风险和高风险人群中的乳糜泻。
乳糜泻的医疗资源利用和成本:美国索赔分析。
Am J Gastroenterol. 2020 Nov;115(11):1821-1829. doi: 10.14309/ajg.0000000000000759.
Therap Adv Gastroenterol. 2012 Jan;5(1):37-47. doi: 10.1177/1756283X11417038.
4
Burden of celiac disease in the Mediterranean area.地中海地区的乳糜泻负担。
World J Gastroenterol. 2011 Dec 7;17(45):4971-8. doi: 10.3748/wjg.v17.i45.4971.
5
The global burden of childhood coeliac disease: a neglected component of diarrhoeal mortality?全球儿童乳糜泻负担:腹泻死亡率中的一个被忽视的组成部分?
PLoS One. 2011;6(7):e22774. doi: 10.1371/journal.pone.0022774. Epub 2011 Jul 26.
6
The prevalence of celiac disease in Europe: results of a centralized, international mass screening project.欧洲乳糜泻的患病率:一项集中式国际大规模筛查项目的结果。
Ann Med. 2010 Dec;42(8):587-95. doi: 10.3109/07853890.2010.505931.
7
Morbidity and mortality among older individuals with undiagnosed celiac disease.老年未确诊乳糜泻患者的发病率和死亡率。
Gastroenterology. 2010 Sep;139(3):763-9. doi: 10.1053/j.gastro.2010.05.041. Epub 2010 Jun 1.
8
The economics of coeliac disease: a population-based study.乳糜泻的经济学研究:基于人群的研究。
Aliment Pharmacol Ther. 2010 Jul;32(2):261-9. doi: 10.1111/j.1365-2036.2010.04327.x. Epub 2010 Apr 8.
9
Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet.大规模筛查乳糜泻的成本效益取决于诊断的时滞和无麸质饮食的生活质量。
Aliment Pharmacol Ther. 2010 Apr;31(8):901-10. doi: 10.1111/j.1365-2036.2010.04242.x. Epub 2010 Jan 19.
10
Increased prevalence and mortality in undiagnosed celiac disease.未确诊的乳糜泻患病率和死亡率增加。
Gastroenterology. 2009 Jul;137(1):88-93. doi: 10.1053/j.gastro.2009.03.059. Epub 2009 Apr 10.